ArticleBMC medical informatics and decision making2024
Development of brain tumor radiogenomic classification using GAN-based augmentation of MRI slices in the newly released gazi brains dataset.
Article in BMC medical informatics and decision making, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Deep Learning Revolution in Neuroimaging: Insights from a Bibliometric Analysis (2014-2024).Neuroinformatics · 2026Review
- Advances in artificial intelligence and thermal analysis for brain tumor detection: a review of models, methods, and modalities.Frontiers in artificial intelligence · 2026Review
- Strategies to Improve the Robustness and Generalizability of Deep Learning Segmentation and Classification in Neuroimaging.BioMedInformatics · 2025Article
- Dual-Stream Contrastive Latent Learning Generative Adversarial Network for Brain Image Synthesis and Tumor Classification.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significant progress has been made recently with the contribution of technological advances in studies on brain cancer. Regarding this, identifying and correctly classifying tumors is a crucial task in the field of medical imaging. The disease-related tumor classification problem, on which deep learning technologies have also become a focus, is very important in the diagnosis and treatment of the disease. The use of deep learning models has shown promising results in recent years. However, the sparsity of ground truth data in medical imaging or inconsistent data sources poses a significant challenge for training these models. The utilization of StyleGANv2-ADA is proposed in this paper for augmenting brain MRI slices to enhance the performance of deep learning models. Specifically, augmentation is applied solely to the training data to prevent any potential leakage. The StyleGanv2-ADA model is trained with the Gazi Brains 2020, BRaTS 2021, and Br35h datasets using the researchers' default settings. The effectiveness of the proposed method is demonstrated on datasets for brain tumor classification, resulting in a notable improvement in the overall accuracy of the model for brain tumor classification on all the Gazi Brains 2020, BraTS 2021, and Br35h datasets. Importantly, the utilization of StyleGANv2-ADA on the Gazi Brains 2020 Dataset represents a novel experiment in the literature. The results show that the augmentation with StyleGAN can help overcome the challenges of working with medical data and the sparsity of ground truth data. Data augmentation employing the StyleGANv2-ADA GAN model yielded the highest overall accuracy for brain tumor classification on the BraTS 2021 and Gazi Brains 2020 datasets, together with the BR35H dataset, achieving 75.18%, 99.36%, and 98.99% on the EfficientNetV2S models, respectively. This study emphasizes the potency of GANs for augmenting medical imaging datasets, particularly in brain tumor classification, showcasing a notable increase in overall accuracy through the integration of synthetic GAN data on the used datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.